improving outcomes in hcc with immunotherapy
Published 3 years ago • 334 plays • Length 1:56Download video MP4
Download video MP3
Similar videos
-
1:57
recent immunotherapy advances in hcc management
-
1:10
the impact of immunotherapy and checkpoint inhibition in treating hcc
-
1:21
unmet needs in immunotherapy for hepatocellular carcinoma
-
40:13
improving outcomes in intermediate to advanced hcc: a multidisciplinary tumor board
-
24:30
reviewing the outcomes in hcc with 1st line immunotherapy: when is the right time to switch?
-
1:05:05
hcc: optimizing outcomes with new and emerging treatment approaches
-
3:10
advancements in immunotherapy for hepatocellular carcinoma
-
1:09
keynote-224: improving hcc outcomes with pembrolizumab
-
1:23
improving upon immunotherapy advances in hcc
-
3:42
imbrave050: adjuvant atezolizumab with bevacizumab in high-risk hcc
-
1:31:51
it takes a team to improve hcc outcomes
-
19:09
immunotherapeutic management of hepatocellular carcinoma: current options and future possibilities
-
4:21
the use of immunotherapy in hcc – in depth subgroup analyses and challenges
-
0:42
proposing the best met inhibitor to improve anti-pd-1 efficacy in hcc
-
44:44
the increasing role of immunotherapy in the management of hcc
-
2:09
keynote-240: pembrolizumab in advanced hcc
-
59:57
exploring new treatment options in hcc
-
53:05
update in the clinical management of hepatocellular carcinoma
-
1:02:48
harnessing the power of immunotherapy in hcc and btc: the past, present, and future